Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03714191
Recruitment Status : Completed
First Posted : October 22, 2018
Last Update Posted : July 21, 2021
Sponsor:
Information provided by (Responsible Party):
NYU Langone Health

Brief Summary:
The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The BPA was designed to help facilitate tobacco cessation interventions; it is part of the The Centers for Medicare & Medicaid Services (CMS) Quality Payment Program (QPP). The purpose of the project is to optimize this BPA utilization and improve patient outcomes by comparing multiple versions of the tobacco cessation BPA.

Condition or disease Intervention/treatment
Tobacco Use Cessation Other: Patient Outcomes Other: Billing documentation Other: Regulatory

Layout table for study information
Study Type : Observational
Actual Enrollment : 54417 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Using Rapid Cycle Randomized Controlled Trials to Study a Tobacco Cessation Best Practice Advisory.
Actual Study Start Date : October 3, 2018
Actual Primary Completion Date : May 24, 2019
Actual Study Completion Date : February 29, 2020

Group/Cohort Intervention/treatment
Improved outcomes Other: Patient Outcomes
The intervention includes different versions of the BPA design and message.

Regulatory reminder Other: Regulatory
The intervention includes different versions of the BPA design and message.

Billing and documentation Other: Billing documentation
The intervention includes different versions of the BPA design and message.




Primary Outcome Measures :
  1. Alert acceptance rate [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All providers of patients at NYU Langone Health (including NYU Winthrop) who are identified as currents smokers, as documented in the social history of their patient chart, and are eligible to receive the best practice advisory for tobacco cessation.
Criteria

Inclusion Criteria:

  • All providers of patients at NYU Langone Health (including NYU Winthrop) who are identified as currents smokers, as documented in the social history of their patient chart, and are eligible to receive the best practice advisory for tobacco cessation.

Exclusion Criteria:

  • non smokers

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03714191


Locations
Layout table for location information
United States, New York
New York University School of Medicine
New York, New York, United States, 10016
Sponsors and Collaborators
NYU Langone Health
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: NYU Langone Health
ClinicalTrials.gov Identifier: NCT03714191    
Other Study ID Numbers: QI-Tobacco Cessation
First Posted: October 22, 2018    Key Record Dates
Last Update Posted: July 21, 2021
Last Verified: July 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No